Jefferies has downgraded Bausch Health (NYSE:BHC) to hold from buy, citing news that a possible sale of its Bausch+Lomb (NYSE:BLCO) unit to a private equity group has fallen through. "While ownership ...

Securitas AB's organic growth for the fourth quarter matched Jefferies' forecast of 4.0% but showed a sequential slowdown from the 4.6% growth in the third quarter. The group's revenue reached SEK ...

Shares of American International Group, Inc. (NYSE:AIG – Get Free Report) have been assigned an average recommendation of ...

French cosmetics group L'Oreal reported on Thursday the slowest quarterly rise in growth since the height of the pandemic, missing expectations, as Chinese demand stayed weak and growth in North ...

Precious metal miners shone as the price of gold hit record highs amid global trade war fears after President Trump imposed ...

Meanwhile, growth is back in the connectivity division, which the group said “continued to lead the recovery cycle”. The order book is up by 4 per cent, taking the book-to-bill ratio to 1.01 – the ...

Spire Wealth Management raised its position in shares of Xcel Energy Inc. (NASDAQ:XEL – Free Report) by 2.8% in the fourth ...

Q4 2024 Management View CEO Tom Gayner emphasized that Markel Group achieved operating income and returns above targets in 2024. He highlighted strong equity portfolio returns and the performance of ...

Jefferies maintains a Buy rating on JB Pharma citing strong CDMO growth potential and a 34% upside. Know more about it.

Wilson will be based in Melbourne and joins Jarden after its equity capital markets team ended 2024 on the No.5 spot on the ...

In a report released yesterday, Blayne Curtis from Jefferies reiterated a Buy rating on Broadcom (AVGO – Research Report). The company’s shares ...

In a report released today, Wei Sim from Jefferies maintained a Buy rating on Life360 Shs Chess Depository Interests Repr 3 Sh (LIFX – Research ...